Log in to search using one of your social media accounts:

 

Heavy Drinking Could Increase ‘ Bad ’ Bacteria In Mouth, Study Finds
CBS Local – People who drink more than the recommended daily limit of alcohol may harbor an unhealthy mix of bacteria in their mouths, a new study suggests. Researchers found that compared with nondrinkers, those who drank heavily had fewer “good” bacteria in their mouths. They were also hosting more “bad” bacteria — including bugs that have been linked to gum disease, heart disease, and cancer. The study is one of the latest to look at what factors influence the human “microbiome” – the trillions of bacteria and other microbes that naturally dwell in the...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - April 25, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health News Drinking Gum Disease Local TV Microbiome talkers Source Type: news

Novel TKI Plus Chemo Dramatically Shrank Advanced Head & amp; Neck Tumors
AZD1775, a small-molecule, WEE1-targeting TKI, significantly shrunk tumors when administered in combination with cisplatin and docetaxel in a phase I trial. (Source: CancerNetwork)
Source: CancerNetwork - April 25, 2018 Category: Cancer & Oncology Authors: Anne Landry Tags: Head & Neck Cancer Head and Neck Cancer Targets News Source Type: news

A defect in KCa3.1 channel activity limits the ability of CD8+ T cells from cancer patients to infiltrate an adenosine-rich microenvironment
The limited ability of cytotoxic T cells to infiltrate solid tumors hampers immune surveillance and the efficacy of immunotherapies in cancer. Adenosine accumulates in solid tumors and inhibits tumor-specific T cells. Adenosine inhibits T cell motility through the A2A receptor (A2AR) and suppression of KCa3.1 channels. We conducted three-dimensional chemotaxis experiments to elucidate the effect of adenosine on the migration of peripheral blood CD8+ T cells from head and neck squamous cell carcinoma (HNSCC) patients. The chemotaxis of HNSCC CD8+ T cells was reduced in the presence of adenosine, and the effect was greater o...
Source: Signal Transduction Knowledge Environment - April 24, 2018 Category: Science Authors: Chimote, A. A., Balajthy, A., Arnold, M. J., Newton, H. S., Hajdu, P., Qualtieri, J., Wise-Draper, T., Conforti, L. Tags: STKE Research Articles Source Type: news

Celecoxib Lowers Opioid Use Post Head & amp; Neck Cancer Surgery
Decreased opioid use seen after head and neck cancer surgery with free tissue reconstruction (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - April 23, 2018 Category: Cancer & Oncology Tags: Oncology, ENT, Pharmacy, Surgery, Anesthesiology & amp; Pain, Journal, Source Type: news

Celecoxib Lowers Opioid Use Post Head & amp; Neck Cancer Surgery
MONDAY, April 23, 2018 -- For patients undergoing head and neck cancer (HNC) surgery, perioperative use of celecoxib is associated with reduced use of opioids after surgery, according to a study published online April 18 in JAMA Otolaryngology-Head... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 23, 2018 Category: Pharmaceuticals Source Type: news

Most Smokers With Head and Neck Cancer Have Tried to Quit
THURSDAY, April 19, 2018 -- Most active smokers with head and neck squamous cell carcinoma (HNSCC) have made one or more quit attempts, according to a study published online April 12 in JAMA Otolaryngology-Head& Neck Surgery. Samir S.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - April 19, 2018 Category: Pharmaceuticals Source Type: news

Abramson Cancer Canter studies show promise of immunotherapy combinations, including CAR T
(University of Pennsylvania School of Medicine) As immunotherapies continue to make up a larger share of new cancer drugs, researchers are looking for the most effective ways to use these cutting edge treatments in combination with each or with other pre-existing options. New studies from the Abramson Cancer Center are providing clues on potentially effective combinations with CAR T therapy in brain cancer as well as a novel therapeutic target in head and neck cancer, and also providing greater understanding of the mechanisms of resistance in pancreatic cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - April 17, 2018 Category: Cancer & Oncology Source Type: news

Study explores carbohydrates' impact on head, neck cancers
(University of Illinois at Urbana-Champaign) Consuming high amounts of carbohydrates and various forms of sugar during the year prior to treatment for head and neck cancer may increase patients' risks of cancer recurrence and mortality, a new study reports.However, eating moderate amounts of fats and starchy foods such as whole grains, potatoes and legumes after treatment could have protective benefits, reducing patients' risks of disease recurrence and death, said lead author Anna E. Arthur, a professor of food science and human nutrition at the University of Illinois. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 12, 2018 Category: International Medicine & Public Health Source Type: news

5 Trends Medtech Should Be Talking About
Recently I chatted with Candace Roulo, managing editor of Advanced Manufacturing Now, about some of the most important trends in medtech and the technologies that are taking the industry to the next level. Click below to listen to the podcast, or read on for select highlights of the conversation – what I consider to be five trends medtech professionals should be talking about. 128-Advanced_Manufacturing_Now-UBM.mp3 Explore all of these trends in depth at the BIOMEDevice Boston Conference and Expo, April 18-19, 2018. Use promo code "SAVE100" for $100 off conference registration and f...
Source: MDDI - April 6, 2018 Category: Medical Devices Authors: Amanda Pedersen Tags: BIOMEDevice Boston Business Digital Health Source Type: news

NIH researchers use genomics to set squamous cell carcinomas apart from other cancers
Results could advance treatments for head and neck and other cancers. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - April 5, 2018 Category: American Health Source Type: news

Mesothelioma Clinical Trial Opens with Optimism in South Florida
Dr. Chukwuemeka Ikpeazu at the Sylvester Comprehensive Cancer Center has brought hope — where once there was none — to patients in South Florida with unresectable pleural mesothelioma. Ikpeazu is the principal investigator in the multicenter phase II clinical trial involving the much-anticipated immunotherapy drug durvalumab. Pharmaceutical giant AstraZeneca manufactures the drug under the brand name Imfinzi. “I am optimistic, very, very optimistic that this drug will be effective for these patients,” Ikpeazu told Asbestos.com. “All the data, all the earlier studies, are encouraging.” He...
Source: Asbestos and Mesothelioma News - April 4, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors
This review concludes that keratinocyte growth factor is beneficial in the prevention of oral mucositis in adults who are receiving radiotherapy to the head and neck with cisplatin or fluorouracil, or chemotherapy alone for mixed solid and haematological cancers. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 28, 2018 Category: Consumer Health News Source Type: news

Immunotherapy Drugs Causing Vision Issues
The U.S. Food and Drug Administration (FDA) is investigating the potential for three immunotherapy drugs to cause retinal detachment and vision loss. The FDA will consider adding eye toxicities to the warning labels for pembrolizumab (Keytruda), nivolumab (Opdivo) and ipilimumab (Yervoy), which have shown promise in clinical trials involving malignant mesothelioma. All three have already been approved by the FDA for use with metastatic melanoma. Keytruda and Opdivo also have approval for head and neck cancers, colorectal cancers and certain non-small cell lung cancers. The FDA used its Adverse Event Reporting System (FAERS...
Source: Asbestos and Mesothelioma News - March 27, 2018 Category: Environmental Health Authors: Daniel King Source Type: news

Accurately identifying aggressive head and neck cancers
(Case Western Reserve University) Case Western Reserve University's Center for Computational Imaging and Personalized Diagnostics (CCIPD) is leading a partnership working toward the first clinical trials to determine the aggressiveness of-and appropriate treatment for-certain head and neck cancers.Head and neck cancers (squamous cell carcinomas or HNSCC) represent more than half-a-million cases and 300,000 deaths a year, making them the sixth-leading cancer worldwide, according to the World Health Organization. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - March 27, 2018 Category: Cancer & Oncology Source Type: news

No Chemo Benefit for Head and Neck Skin Cancer
(MedPage Today) -- Radiotherapy alone provides similar disease control (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - March 20, 2018 Category: Primary Care Source Type: news

Hidden Cancers Uncovered With Glowing Dyes
PHILADELPHIA (AP) — It was an ordinary surgery to remove a tumor — until doctors turned off the lights and the patient’s chest started to glow. A spot over his heart shined purplish pink. Another shimmered in a lung. They were hidden cancers revealed by fluorescent dye, an advance that soon may transform how hundreds of thousands of operations are done each year. Surgery has long been the best way to cure cancer. If the disease recurs, it’s usually because stray tumor cells were left behind or others lurked undetected. Yet there’s no good way for surgeons to tell what is cancer and what is not...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - March 15, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Local News Cancer Dr. Mallika Marshall Local TV TumorGlow Source Type: news

TAE Life Sciences raises $40m for neutron beam cancer treatment
TAE Life Sciences said yesterday it raised $40 million in venture capital to support the development of its neutron beam technology designed as a potential treatment for head and neck, glioblastoma multiforme and other cancers. The newly launched Foothill Ranch, Calif.-based company, which operates as a subsidiary of fusion energy company TAE Technologies, is developing neutron beam technology intended for Boron Neutron Capture Therapy. As part of the company’s launch, it announced that it is partnering with Chinese BNCT company Neuboron Medtech, and that its first neutron beam system will be delivered to Neuboron fo...
Source: Mass Device - March 13, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Oncology taelifesciences Source Type: news

HPV Causes Cancer — A Vaccine Can Prevent It
More than 30,000 Americans develop one of several kinds of cancer each year caused by the human papillomavirus (HPV) — some of which will kill them. Fortunately, physicians say a too-seldom-used vaccine can protect people from HPV-caused cancers of the cervix, vulva, vagina, penis, anus, and oropharynx (head and neck). (Source: TMA News Room)
Source: TMA News Room - March 1, 2018 Category: Consumer Health News Source Type: news

Multimodal Imaging of Head and Neck Squamous Cell Carcinoma Multimodal Imaging of Head and Neck Squamous Cell Carcinoma
Review standard and multimodal cross-sectional imaging for evaluation and management of head and neck SCC.Cancer Control: Journal of the Moffitt Cancer Center (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 27, 2018 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Adding Nivolumab to Standard First-Line Therapy Feasible in Advanced Head and Neck Cancer
An early phase trial found that it is feasible to combine nivolumab immunotherapy with radiation therapy and chemotherapy in patients with newly diagnosed local-regionally advanced head and neck cancers. (Source: CancerNetwork)
Source: CancerNetwork - February 20, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Head & Neck Cancer News Radiation Oncology Source Type: news

Durvalumab Shows Promise in Advanced Head and Neck Cancer
A phase II trial found that the immune checkpoint inhibitor durvalumab has promising clinical activity and is well tolerated both as monotherapy and in combination with tremelimumab in patients with heavily pretreated recurrent or metastatic head and neck cancer, whose tumors are PD-L1 low or negative. (Source: CancerNetwork)
Source: CancerNetwork - February 20, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Head & Neck Cancer News Source Type: news

Suicide Among Cancer Survivors -- Highest Risk in HNC Suicide Among Cancer Survivors -- Highest Risk in HNC
Compared to all other cancer types, with one exception, the risk for suicide is significantly higher among survivors of head and neck cancer (HNC).Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 20, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Reduced RT Feasible in Chemo-Sensitive HPV-Associated Head and Neck Cancer
Patients with human papillomavirus –associated head and neck cancers who respond well to induction therapy can receive substantially lower doses of radiation and still achieve good safety and efficacy outcomes, according to a new phase II trial. (Source: CancerNetwork)
Source: CancerNetwork - February 20, 2018 Category: Cancer & Oncology Authors: Dave Levitan Tags: Head & Neck Cancer News Radiation Oncology Source Type: news

Novel De-escalation Approach for HPV+ Head and Neck Cancer Novel De-escalation Approach for HPV+ Head and Neck Cancer
A study of a novel approach to de-escalating treatment for HPV-positive head and neck cancer shows excellent pathologic complete response and survival outcomes.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - February 15, 2018 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Florida woman is 12th person in world to have rare cancer
Rose Yarusskaya of Florida is in her third round of a battle against a rare head and neck cancer that keeps coming back due to an even rarer mutation that keeps her body from fighting tumors. (Source: the Mail online | Health)
Source: the Mail online | Health - February 14, 2018 Category: Consumer Health News Source Type: news

Cabozantinib potential option to treat differentiated thyroid cancer
According to results that will be presented at the 2018 Multidisciplinary Head and Neck Cancers Symposium in Arizona this Friday, tumours treated with the drug shrunk in 97% of patients.Science Daily (Source: Society for Endocrinology)
Source: Society for Endocrinology - February 14, 2018 Category: Endocrinology Source Type: news

Lower-dose radiation effective, safe for HPV+ head & neck cancer after induction chemo
(American Society for Radiation Oncology) Results of the phase II OPTIMA clinical trial indicate that patients with head and neck cancers associated with the human papillomavirus (HPV), including those with advanced nodal disease, can receive substantially lower radiation doses safely and effectively if they respond to induction chemotherapy initially. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

Phase II trial shows activity of durvalumab in recurrent/metastatic head and neck cancer
(American Society for Radiation Oncology) Analysis of the phase II CONDOR trial indicates that the immune checkpoint inhibitor durvalumab is tolerable among heavily pre-treated patients with recurrent or metastatic head and neck cancer and has the potential to slow growth in tumors with low or negative expression of the PD-L1 protein. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

Nivolumab immunotherapy safe, feasible during chemoradiation for adv. head and neck cancer
(American Society for Radiation Oncology) Analysis of a clinical trial, RTOG Foundation 3504, finds that nivolumab immunotherapy can be administered safely in conjunction with radiation therapy and chemotherapy for patients with newly diagnosed local-regionally advanced head and neck cancers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

Head and Neck Cancer
Title: Head and Neck CancerCategory: Diseases and ConditionsCreated: 9/19/2007 12:00:00 AMLast Editorial Review: 2/12/2018 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - February 12, 2018 Category: Cancer & Oncology Source Type: news

Cancer-Causing HPV Can Hide in the Throat
Testing can detect HPV before it leads to cervical cancer. However, that's not the case for head and neck cancers, the researchers said. (Source: WebMD Health)
Source: WebMD Health - February 7, 2018 Category: Consumer Health News Source Type: news

Cancer-Causing HPV Can Hide in the Throat
WEDNESDAY, Feb. 7, 2018 -- Human papilloma virus (HPV) could be lurking in your throat. It's known that strains of the virus can cause cervical cancer. And the virus can also cause certain forms of head and neck cancer, according to researchers... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - February 7, 2018 Category: General Medicine Source Type: news

HPV May Lurk In Your Throat
URMC researchers found human papilloma virus (HPV), the culprit behind cervical and head and neck cancers, hiding in small pockets on the surface of tonsils. They believe HPV may evade the immune system in this hiding place, allowing the virus to lay in wait for an opportunity to reinstate an infection or invade the tonsil tissue to develop cancer. (Source: University of Rochester Medical Center Press Releases)
Source: University of Rochester Medical Center Press Releases - January 31, 2018 Category: Universities & Medical Training Authors: University of Rochester Medical Center Source Type: news

HPV may lurk in your throat
(University of Rochester Medical Center) URMC researchers found human papilloma virus (HPV), the culprit behind cervical and head and neck cancers, hiding in small pockets on the surface of tonsils. They believe HPV may evade the immune system in this hiding place, allowing the virus to lay in wait for an opportunity to reinstate an infection or invade the tonsil tissue to develop cancer. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 31, 2018 Category: International Medicine & Public Health Source Type: news

Oral HPV Infection Rate Is Alarmingly High in US Men Oral HPV Infection Rate Is Alarmingly High in US Men
A large population-based study argues for more rigorous efforts to vaccinate against HPV infection and prevent subsequent head and neck cancers, says Dr Markman.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 25, 2018 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

Depressive Symptoms Linked to Lower Head and Neck Cancer Survival Depressive Symptoms Linked to Lower Head and Neck Cancer Survival
Patients with head and neck cancer who report depressive symptoms have poorer treatment responses and significantly shorter survival, compared with other patients, researchers report.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - January 24, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Solving the mystery of a shapeshifting neck tumor
Jaedin, 10 years old, holds the control for a remote-controlled race car, Christmas 2017. Amanda Brown couldn’t shake an uneasy intuition that something just seemed “off” throughout her second pregnancy. During a scheduled caesarian section at her local hospital in North Carolina, her instinct proved to be true. “I had given birth to my first son by C-section so I knew what to expect,” Amanda says. “But this time around, as the surgeons totally stalled in the middle of the delivery, I thought to myself, ‘it doesn’t take this long to pull a baby out.’” When her son...
Source: Thrive, Children's Hospital Boston - January 24, 2018 Category: Pediatrics Authors: Kat J. McAlpine Tags: Diseases & Conditions Our Patients’ Stories Center for Airway Disorders cervical teratoma Dr. Reza Rahbar germ cell tumor Neck and Skullbase Surgery Program at Boston Children's NICU Solid Tumors Center at Dana-Farber/Boston Children's Source Type: news

Study provides new guidelines for assessing severity of head and neck cancers
(Cedars-Sinai Medical Center) Cedars-Sinai investigators have developed a new, more accurate set of guidelines for assessing the severity of head and neck cancers and predicting patient survival. The new guidelines, outlined in a study recently published in the Journal of Clinical Oncology, center around counting the number of malignant lymph nodes found in each patient. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 24, 2018 Category: Cancer & Oncology Source Type: news

Depressive symptoms linked to shorter survival in patients with head and neck cancer
(Wiley) In a study of patients with head and neck cancer, even mild depressive symptoms were associated with poorer overall survival. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 22, 2018 Category: Cancer & Oncology Source Type: news

UCLA study describes structure of tumor herpes virus associated with Kaposi ’s sarcoma
UCLA researchers have provided the first description of the structure of the herpes virus associated with Kaposi ’s sarcoma, a type of cancer.The discovery answers important questions about how the virus spreads and provides a potential roadmap for the development of antiviral drugs to combat both that virus and the more common Epstein-Barr virus, which is present in more than 90 percent of the adult population and is believed to have a nearly identical structure.In the study, published in the journal  Nature, the UCLA team showed in the laboratory that an inhibitor could be developed to break down the herpes vi...
Source: UCLA Newsroom: Health Sciences - January 20, 2018 Category: Universities & Medical Training Source Type: news

Medical News Today: Head and neck cancer: Acid reflux may raise risk in seniors
A new study finds a strong association between acid reflux and cancers of the respiratory and upper digestive tracts in older adults. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 30, 2017 Category: Consumer Health News Tags: Cancer / Oncology Source Type: news

Anesthesia for Head and Neck Cancer Surgery Anesthesia for Head and Neck Cancer Surgery
Head and neck cancer patients may present with a difficult airway, as well as significant comorbidities. How should they be assessed and managed for anesthesia?BJA Education (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - December 29, 2017 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Nanobiotix ’s nanoparticle-immunotherapy trial wins FDA approval
Nanobiotix (EMA:NANO) said today that the FDA has approved its IND application for a cancer trial combining its radiotherapy-activated nanoparticle tech with an anti-PD1 antibody. The Phase I/II trial is slated to evaluate the safety and efficacy of Nanobiotix’s NBTXR3 product administered with checkpoint inhibitors in three groups of patients with recurrent or metastatic head and neck squamous cell carcinoma or with metastatic non-small cell lung cancer. Get the full story at our sister site, Drug Delivery Business News. The post Nanobiotix’s nanoparticle-immunotherapy trial wins FDA approval appeare...
Source: Mass Device - December 26, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Clinical Trials Drug-Device Combinations Food & Drug Administration (FDA) Oncology Pharmaceuticals Wall Street Beat nanobiotix Source Type: news

GERD Associated with Increased Risk for Head and Neck Cancers
Gastroesophageal reflux disease (GERD) is associated with significantly increased risk for cancers of the upper aerodigestive tract in older adults, according to a case-control... (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - December 22, 2017 Category: Primary Care Source Type: news

Chronic Heartburn Tied to Higher Odds for Head, Neck Cancers
New research suggests people with chronic acid reflux might have higher odds for even more dangerous foes -- head and neck cancers (Source: WebMD Health)
Source: WebMD Health - December 21, 2017 Category: Consumer Health News Source Type: news

Chronic Heartburn Tied to Higher Odds for Head, Neck Cancers
Source: HealthDay Related MedlinePlus Pages: GERD, Head and Neck Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - December 21, 2017 Category: Consumer Health News Source Type: news

Chronic Heartburn Tied to Higher Odds for Head, Neck Cancers
THURSDAY, Dec. 21, 2017 -- Millions of American seniors suffer the discomfort of chronic acid reflux. Now, new research suggests the condition might raise their odds for even more dangerous foes -- head and neck cancers. The research can't prove... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 21, 2017 Category: General Medicine Source Type: news

Acid reflux associated with head and neck cancers in older adults
(JAMA Network) Acid reflux was associated with cancer of the respiratory and upper digestive tracts in older adults. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 21, 2017 Category: International Medicine & Public Health Source Type: news

A systematic review of alcohol interventions for people living with and beyond cancer
Conclusion This review highlights there is a lack of interventions which have a specific focus on reducing how much alcohol people are drinking following a diagnosis for cancer.  Alcohol use can increase the risk of secondary or recurrent cancer, especially in people who have been diagnosed with breast cancer, and head and neck cancers. Therefore, there is a need for more research to explore the potential for interventions to encourage people who have been diagnosed with cancer to drink less alcohol, which can reduce this risk. Further Information Contact details for corresponding author: Dr Grant J. McGeechan, C1.1...
Source: Alcohol Research UK - December 20, 2017 Category: Addiction Authors: admin Tags: Alcohol Insights Source Type: news

Head and Neck Cancer Survivors Have Long-lasting Cognitive Problems Head and Neck Cancer Survivors Have Long-lasting Cognitive Problems
Patients who survive head and neck cancer may be more likely to experience declines in cognitive function than people who don ’ t have these tumors, a recent study suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 14, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news